indazoles and Anemia
indazoles has been researched along with Anemia in 12 studies
Research
Studies (12)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hashimoto, K; Kanao, H; Kawakami, K; Mori, Y; Shibata, N; Shimizu, H; Soejima, A; Sugisaki, T; Yamaguchi, M; Yokokawa, T; Yunokawa, M | 1 |
| Bertucci, F; Blay, JY; Bompas, E; Brodowicz, T; Chaigneau, L; Chevreau, C; Decoupigny, E; Delcambre, C; Italiano, A; Laroche, L; Le Cesne, A; Le Deley, MC; Mir, O; Penel, N; Ray-Coquard, I; Saada-Bouzid, E; Salas, S; Taieb, S; Vanseymortier, M; Wallet, J | 1 |
| Al-Samkari, H; Gossage, JR; McCrae, KR; Menon, KVN; Parambil, JG; Pederson, DP; Sprecher, DL; Timmerman, KL; Woodard, TD | 1 |
| Choe, SW; Kim, MJ; Kim, YH; Lee, YJ; P Oh, S; Sprecher, D | 1 |
| Fukuda, T; Goto, R; Hashimoto, M; Ishiyama, T; Muramatsu, S; Tanaka, N; Ueda, K; Watanabe, K | 1 |
| Gunderson, CC; Matulonis, U; Moore, KN | 1 |
| O'Cearbhaill, RE | 1 |
| Bauer, TM; Bendell, JC; Burris, HA; Hinson, JM; Infante, JR; Jones, S; Orlemans, EO; Ramanathan, RK; Tibes, R; Von Hoff, DD; Weiss, GJ | 1 |
| Hata, H; Imafuku, K; Inamura, Y; Kitamura, S; Shimizu, H; Yanagi, T; Yoshino, K | 1 |
| Antimi, M; Botti, C; Carlini, P; Ceribelli, A; Cognetti, F; Cortesi, E; Di Cosimo, S; Di Filippo, F; Di Lauro, L; Ferretti, G; Giannarelli, D; Lopez, M; Marolla, P; Mottolese, M; Naso, G; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E; Vici, P | 1 |
| Baù, MG; Berruti, A; Bottini, A; Buniva, T; Danese, S; Dogliotti, L; Farris, A; Moro, G; Porcile, G; Richiardi, G; Zola, P | 1 |
| Hudetz, AG; Kampine, JP; Wood, JD | 1 |
Reviews
1 review(s) available for indazoles and Anemia
| Article | Year |
|---|---|
Management of the toxicities of common targeted therapeutics for gynecologic cancers.
Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Autoimmune Diseases; Bevacizumab; Diarrhea; Epistaxis; Fatigue; Female; Genital Neoplasms, Female; Headache; Hemorrhage; Humans; Hypertension; Indazoles; Intestinal Perforation; Molecular Targeted Therapy; Nausea; Neutropenia; Poly(ADP-ribose) Polymerase Inhibitors; Precision Medicine; Proteinuria; Pyrimidines; Risk Assessment; Sulfonamides; Vomiting; Water-Electrolyte Imbalance | 2018 |
Trials
4 trial(s) available for indazoles and Anemia
| Article | Year |
|---|---|
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Cross-Over Studies; Diarrhea; Disease Progression; Double-Blind Method; Female; Humans; Indazoles; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Phenylurea Compounds; Pyridines; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2020 |
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Benzamides; Biological Availability; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Glycine; Heterocyclic Compounds, 4 or More Rings; HSP90 Heat-Shock Proteins; Humans; Indazoles; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Prodrugs; Vision Disorders | 2014 |
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Erythropoiesis; Female; Granulocyte Colony-Stimulating Factor; Humans; Indazoles | 2006 |
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.
Topics: Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Indazoles; Infusions, Intravenous; Middle Aged; Nausea; Pilot Projects; Thrombocytopenia; Treatment Outcome; Vomiting | 1998 |
Other Studies
7 other study(ies) available for indazoles and Anemia
| Article | Year |
|---|---|
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity.
Topics: Anemia; Creatinine; Female; Humans; Indazoles; Neutropenia; Ovarian Neoplasms; Risk Factors; Thrombocytopenia | 2023 |
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
Topics: Anemia; Epistaxis; Humans; Indazoles; Pyrimidines; Retrospective Studies; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic | 2022 |
Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Administration, Oral; Administration, Topical; Anemia; Angiogenesis Inhibitors; Animals; Arteriovenous Malformations; Disease Models, Animal; Erlotinib Hydrochloride; Gastrointestinal Hemorrhage; Hemoglobins; Image Processing, Computer-Assisted; Indazoles; Mice; Mice, Knockout; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Skin; Sorafenib; Sulfonamides; Sulfones; Telangiectasia, Hereditary Hemorrhagic; Tyrosine; Vascular Endothelial Growth Factor A; Wound Healing | 2017 |
Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.
Topics: Anemia; Animals; Anti-Infective Agents; Chronic Disease; Half-Life; Hepcidins; Indazoles; Inhibitory Concentration 50; Interleukin-6; Mice; Mice, Inbred C57BL; Microsomes, Liver; Structure-Activity Relationship | 2017 |
Using PARP Inhibitors in Advanced Ovarian Cancer.
Topics: Anemia; Creatinine; Drug Administration Schedule; Drug Interactions; Exanthema; Fatigue; Female; Genes, BRCA1; Genes, BRCA2; Heart Rate; Humans; Hypertension; Indazoles; Leukopenia; Mutation; Myelodysplastic Syndromes; Nasopharyngitis; Nausea; Ovarian Neoplasms; Piperidines; Pneumonia; Poly(ADP-ribose) Polymerase Inhibitors; Thrombocytopenia; Transaminases; Vomiting | 2018 |
Pazopanib does not bring remarkable improvement in patients with angiosarcoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Chemical and Drug Induced Liver Injury; Disease-Free Survival; Fatigue; Female; Hemangiosarcoma; Humans; Indazoles; Male; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2017 |
7-Nitroindazole impedes erythrocyte flow response to isovolemic hemodilution in the cerebral capillary circulation.
Topics: Anemia; Animals; Blood Flow Velocity; Blood Pressure; Capillaries; Cerebrovascular Circulation; Enzyme Inhibitors; Erythrocytes; Hematocrit; Hemodilution; Hyperemia; Hypoxia, Brain; Indazoles; Male; Microscopy, Video; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley | 2000 |